{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:07:24Z","timestamp":1789985244022,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jbspin.2017.05.011","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T19:19:55Z","timestamp":1495135195000},"page":"285-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["New Markers for Adult-Onset Still's Disease"],"prefix":"10.1016","volume":"85","author":[{"given":"St\u00e9phane","family":"Mitrovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Fautrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2017.05.011_bib0305","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.30.2.121","article-title":"Still's disease in the adult","volume":"30","author":"Bywaters","year":"1971","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0310","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.berh.2008.08.006","article-title":"Adult-onset Still disease","volume":"22","author":"Fautrel","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0315","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0320","first-page":"424","article-title":"Preliminary criteria criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0325","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10067-002-0680-3","article-title":"Fever of unknown origin: a review of 20 patients with adult-onset Still's disease","volume":"22","author":"Mert","year":"2003","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0330","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MD.0000000000000021","article-title":"Adult-onset Still disease: manifestations, treatments, outcome, and prognostic factors in 57 patients","volume":"93","author":"Gerfaud-Valentin","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0335","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00296-011-1801-6","article-title":"Therapeutic responses and prognosis in adult-onset Still's disease","volume":"32","author":"Kim","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0340","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for new set of classification criteria for adult-onset still disease","volume":"81","author":"Fautrel","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0345","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12026-014-8561-9","article-title":"Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart","volume":"61","author":"Jamilloux","year":"2015","journal-title":"Immunol Res"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0350","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.autrev.2014.08.032","article-title":"Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions","volume":"13","author":"Maria","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0355","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clim.2016.05.010","article-title":"Cytokine profile in adult-onset Still's disease: comparison with systemic juvenile idiopathic arthritis","volume":"169","author":"Inoue","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0360","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1586\/1744666X.2015.1037287","article-title":"Presentation and diagnosis of adult-onset Still's disease: the implications of current and emerging markers in overcoming the diagnostic challenge","volume":"11","author":"Colafrancesco","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0365","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nrrheum.2013.101","article-title":"How should we approach classification of autoinflammatory diseases?","volume":"9","author":"Grateau","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0370","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/path.4812","article-title":"The burgeoning field of innate immune-mediated disease and autoinflammation","volume":"241","author":"Peckham","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0375","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1568-9972(03)00091-0","article-title":"Pathogenesis of hemophagocytic syndrome (HPS)","volume":"3","author":"Larroche","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0380","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrrheum.2013.14","article-title":"Mechanistic biomarkers for clinical decision making in rheumatic diseases","volume":"9","author":"Robinson","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0385","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13075-016-1069-z","article-title":"Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks?","volume":"18","author":"Gohar","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0390","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/acr.22194","article-title":"Clinical manifestations of adult-onset Still's disease presenting with erosive arthritis: association with low levels of ferritin and Interleukin-18","volume":"66","author":"Ichida","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0395","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","article-title":"Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis","volume":"49","author":"Shimizu","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0400","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0405","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3899\/jrheum.100247","article-title":"Clinical manifestations but not cytokine profiles differentiate adult-onset still's disease and sepsis","volume":"37","author":"Rau","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0410","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1136\/annrheumdis-2013-203666","article-title":"Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes","volume":"73","author":"Piram","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0415","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10067-014-2487-4","article-title":"Life-threatening complications of adult-onset Still's disease","volume":"33","author":"Efthimiou","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0420","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12916-016-0738-8","article-title":"Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers","volume":"14","author":"Ruscitti","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0425","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.23437","article-title":"The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0430","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0140-6736(87)90204-2","article-title":"Increased serum ferritin levels in adult Still's disease","volume":"1","author":"Ota","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0435","first-page":"1058","article-title":"Adult Still's disease: a multicenter survey of Japanese patients","volume":"17","author":"Ohta","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0440","first-page":"322","article-title":"Diagnostic value of ferritin and glycosylated ferritin in adult-onset Still's disease","volume":"28","author":"Fautrel","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0445","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0002-9343(99)80015-1","article-title":"Extremely elevated serum ferritin levels in a university hospital: associated diseases and clinical significance","volume":"98","author":"Lee","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0450","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.semarthrit.2010.12.006","article-title":"The evolution of adult-onset Still disease: an observational and comparative study in a cohort of 76 Italian patients","volume":"41","author":"Colina","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0455","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome Still's disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Ros\u00e1rio","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0460","first-page":"890","article-title":"Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease","volume":"21","author":"Van Reeth","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0465","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/ard.59.5.347","article-title":"Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still's disease","volume":"59","author":"Vigne","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0470","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5","article-title":"Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease","volume":"44","author":"Kawashima","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0475","first-page":"2422","article-title":"Serum cytokine profiles in patients with adult onset Still's disease","volume":"30","author":"Choi","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0480","first-page":"2189","article-title":"Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0485","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3899\/jrheum.130575","article-title":"Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis","volume":"41","author":"Priori","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0490","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3899\/jrheum.120079","article-title":"Serum S100A8\/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease","volume":"39","author":"Kim","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0495","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/ard.2003.016428","article-title":"Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis","volume":"63","author":"Rooney","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0500","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/ard.2008.093781","article-title":"Lymph node IL-18 expression in adult-onset Still's disease","volume":"68","author":"Conigliaro","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0505","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/rheumatology\/keq397","article-title":"Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis","volume":"50","author":"Priori","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0510","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/1529-0131(200107)44:7<1716::AID-ART298>3.0.CO;2-I","article-title":"Interleukin-18 as a novel diagnostic indicator of disease severity in adult-onset Still's disease","volume":"44","author":"Kawaguchi","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0515","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/03009742.2013.824023","article-title":"Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease","volume":"43","author":"Jung","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0520","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/sj.gene.6363922","article-title":"Association between adult-onset Still's disease and interleukin-18 gene polymorphisms","volume":"3","author":"Sugiura","year":"2002","journal-title":"Genes Immun"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0525","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3899\/jrheum.090662","article-title":"Cytokine profiles of macrophage activation syndrom associated with rheumatic diseases","volume":"37","author":"Maruyama","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0530","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1002\/art.20631","article-title":"Proinflammatory S100 proteins in arthritis and autoimmune disease","volume":"50","author":"Foell","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0535","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3899\/jrheum.091120","article-title":"Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease","volume":"37","author":"Jung","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0540","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17081342","article-title":"TLR4 endogenous ligand S100A8\/A9 levels in adult-onset Still's disease and their association with disease activity and clinical manifestatons","author":"Kim","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0545","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1002\/art.24137","article-title":"S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin","volume":"58","author":"Wittkowksi","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0550","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/art.20125","article-title":"Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations","volume":"50","author":"Foell","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0555","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.3899\/jrheum.140651","article-title":"Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease","volume":"41","author":"Bae","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0560","first-page":"123","article-title":"Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases","volume":"24","author":"Scir\u00e8","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0565","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12891-015-0569-3","article-title":"The potential role of advanced glycation end products (AGEs) and soluble recptors for AGEs (sRAGE) in the pathogenesis of adult-onset Still's disease","volume":"16","author":"Chen","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0570","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13075-015-0773-4","article-title":"Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still's disease","volume":"17","author":"Han","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365513.2011.626868","article-title":"Soluble CD163","volume":"72","author":"M\u00f8ller","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0580","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/art.22416","article-title":"The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset juvenile idiopathic arthritis","volume":"56","author":"Bleesing","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0585","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12026-014-8563-7","article-title":"sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia","volume":"60","author":"Colafrancesco","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0590","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.clinbiochem.2008.01.008","article-title":"The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease","volume":"41","author":"Zou","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0595","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/art.21164","article-title":"Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease","volume":"53","author":"Chen","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.05.011_bib0600","doi-asserted-by":"crossref","first-page":"e0168147","DOI":"10.1371\/journal.pone.0168147","article-title":"Metabolic disturbances in adult-onset Still's disease evaluated using liquid chromatography\/mass spectrometry-based metabolic analysis","volume":"11","author":"Chen","year":"2016","journal-title":"Plos One"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X17301021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X17301021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T18:21:11Z","timestamp":1535826071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X17301021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1297319X17301021"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2017.05.011","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Markers for Adult-Onset Still's Disease","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2017.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}